A2AAR/HDAC-IN-1

A2AAR/HDAC-IN-1(compound 14c)是一种口服有效且平衡的 A2AAR/HDAC 双抑制剂,对 A2AAR 的 Ki 为 163.5 nM,对 HDAC1 的 IC50 为 145.3 nM,具有抗癌(anticancer)活性。
产品编号: MS-F60311 CAS No.: 2767560-51-8
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

A2AAR/HDAC-IN-1(compound 14c)是一种口服有效且平衡的 A2AAR/HDAC 双抑制剂,对 A2AAR 的 Ki 为 163.5 nM,对 HDAC1 的 IC50 为 145.3 nM,具有抗癌(anticancer)活性。

生物实验数据

生物活性 A2AAR/HDAC-IN-1 (compound 14c) is an orally active and balanced dual A2AAR/HDAC inhibitor with a Ki of 163.5 nM for A2AAR and an IC50 of 145.3 nM for HDAC1, exhibiting anticancer activity.
IC50 & Target A2A receptor:163.5 ± 14 nM (Ki), A2B (human):>10000 nM (Ki), HDAC3:443.5 ± 27 nM, HDAC8:>10000 nM, HDAC6:>10000 nM, HDAC1:145.3 ± 12 nM, A1AR:503.3 ± 14 nM (Ki), A3 receptor:>10000 nM (Ki), HDAC2:240.2 ± 19 nM
体外研究
(In Vitro)

A2AAR/HDAC-IN-1 (compound 14c) (0-100 μM, 72 h) shows anti-proliferative activities against colon cancer cell lines, CT26 and MC38.
A2AAR/HDAC-IN-1 (0-5 μM, 24 h) increases histone acetylation.
A2AAR/HDAC-IN-1 shows moderate selectivity against A1AR (3-fold) and no significant binding for A2BAR and A3AR.

Cell Proliferation Assay

Cell Line: Colon cancer cell lines (CT26 and MC38)
Concentration: 0-100 μM
Incubation Time: 72 h
Result: Displayed good cytotoxicity in CT26 and MC38 cells, with GI50 values of 0.29 ± 0.03 μM and 0.38 ± 0.03 μM, respectively.

Western Blot Analysis

Cell Line: MC38 mouse colon cancer cells
Concentration: 0, 0.1, 1, and 5 μM
Incubation Time: 24 h
Result: Increased histone H3 and H4 acetylation in a concentration-dependent manner.
体内研究
(In Vivo)

A2AAR/HDAC-IN-1 (compound 14c) (30 or 60 mg/kg, IP, twice daily for 9 days) shows potent anti-tumor effects in the mouse MC38 xenograft model.
A2AAR/HDAC-IN-1 (90 mg/kg, bid; 150 mg/kg, qd; Oral gavage, for 15 days) shows weak tumor suppression.
A2AAR/HDAC-IN-1 (5 mg/kg, IV; 20 mg/kg PO or IP; once) shows an overall favorable pharmacokinetic profile.

Animal Model: Male ICR mice (6-8 weeks, ~25 g body weight, MC38 colon cancer model)
Dosage: 30 or 60 mg/kg
Administration: IP, twice daily for 9 days
Result: Significantly inhibited tumor growth at a dosage of 30 mg/kg (ip, bid), with a tumor growth inhibition (TGI) rate of 68%. At a dosage of 60 mg/kg, the TGI rate was further increased to 85%.
Animal Model: Male ICR mice (6-8 weeks, ~25 g body weight, MC38 colon cancer model)
Dosage: 90 mg/kg, bid; 150 mg/kg, qd
Administration: Oral gavage, twice daily (90 mg/kg) or daily (150 mg/kg), for 15 days
Result: Showed only weak tumor suppression even at a dose of 90 mg/kg (po, bid), with inhibition rates of 44%.
Animal Model: Male ICR mice (6-8 weeks, ~25 g body weight)
Dosage: 5 mg/kg (IV) and 20 mg/kg (PO, IP)
Administration: Orally, IP, or IV; once (Pharmacokinetic Analysis)
Result: Pharmacokinetic Parameters of A2AAR/HDAC-IN-1 in male ICR mice.
PK Parameters po (20 mg/kg) iv (5 mg/kg) ip (20 mg/kg)
Kel (h-1) 0.390 ± 0.187 1.820 ± 0.300 0.844 ± 0.021
t1/2 (h) 2.24 ± 1.16 0.389 ± 0.070 0.83 ± 0.02
Tmax (h) 0.333 ± 0.14 0.25 ± 0.00
Cmax (ng/mL) 3417 ± 1639 4703 ± 735 8411 ± 693
C0 (ng/mL) 6498 ± 1285
AUC0-t (ng/mL·h) 3602 ± 1807 2098 ± 143 10022 ± 931
CL (mL/min/kg) 39.3 ± 2.3 33.5 ± 3.1
分子量

439.47

Formula

C24H21N7O2

CAS 号

2767560-51-8

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
Data Sheet (533 KB) 产品使用指南 (1538 KB)
参考文献
  • . Zhang J, et al. Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives. Eur J Med Chem. 2022 Jun 5;236:114326.  [Content Brief]

  • . Zhang J, et al. Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives. Eur J Med Chem. 2022 Jun 5;236:114326.

A2AAR/HDAC-IN-1 相关分类

  • Cancer
  • 肿瘤靶向治疗 肿瘤代谢与转移
  • Cell Cycle/DNA Damage Epigenetics GPCR/G Protein
  • HDAC Adenosine Receptor
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2